Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Technology | 14.39% |
| 3 | Financials | 10.63% |
| 4 | Industrials | 9.92% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
2276
DELISTED
Sleep Number
SNBR
| $2.25M | ﹤0.01% |
+59,820
| New | +$2.04M |
|
2277
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $2.24M | ﹤0.01% |
+18,800
| New | +$2.19M |
|
|
EDN
2278
Edenor
EDN
$1.01B
| $2.24M | ﹤0.01% |
45,000
-67,500
| -60% | -$3.02M |
|
|
HBMD
2279
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $2.24M | ﹤0.01% |
101,697
-21,003
| -17% | -$449K |
|
2280
Diodes
DIOD
$4.75B
| $2.23M | ﹤0.01% |
+77,951
| New | +$2.42M |
|
|
UBFO
2281
DELISTED
United Security Bancshares
UBFO
| $2.23M | ﹤0.01% |
203,005
+28,790
| +17% | +$285K |
|
2282
SiteOne Landscape Supply
SITE
$4.29B
| $2.23M | ﹤0.01% |
29,100
+10,200
| +54% | +$691K |
|
|
CGNT
2283
DELISTED
Cogentix Medical, Inc.
CGNT
| $2.23M | ﹤0.01% |
708,637
+79,900
| +13% | +$230K |
|
|
BPFH
2284
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $2.23M | ﹤0.01% |
144,300
-195,900
| -58% | -$3.12M |
|
2285
AudioCodes
AUDC
$254M
| $2.22M | ﹤0.01% |
301,700
+76,049
| +34% | +$547K |
|
|
GWPH
2286
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.22M | ﹤0.01% |
+16,820
| New | +$1.98M |
|
2287
China Automotive Systems
CAAS
$142M
| $2.21M | ﹤0.01% |
461,033
-65,000
| -12% | -$329K |
|
|
NS
2288
DELISTED
NuStar Energy L.P.
NS
| $2.21M | ﹤0.01% |
+73,770
| New | +$2.39M |
|
|
PTX
2289
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.19M | ﹤0.01% |
914,750
+95,800
| +12% | +$265K |
|
2290
Ark Restaurants
ARKR
$20.2M
| $2.19M | ﹤0.01% |
80,900
+1,300
| +2% | +$32.2K |
|
2291
Comp X International
CIX
$388M
| $2.18M | ﹤0.01% |
163,700
+800
| +0.5% | +$11.2K |
|
|
STRR
2292
DELISTED
Star Equity Holdings
STRR
| $2.17M | ﹤0.01% |
16,858
| – | – |
|
|
OMED
2293
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.17M | ﹤0.01% |
529,300
+117,700
| +29% | +$512K |
|
|
KL
2294
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $2.17M | ﹤0.01% |
141,000
+10,332
| +8% | +$142K |
|
2295
Boot Barn
BOOT
$4.92B
| $2.16M | ﹤0.01% |
130,300
-83,500
| -39% | -$1M |
|
2296
TAT Technologies
TATT
$537M
| $2.16M | ﹤0.01% |
205,900
+3,000
| +1% | +$32.3K |
|
|
PKD
2297
DELISTED
Parker Drilling Company
PKD
| $2.16M | ﹤0.01% |
144,160
+34,533
| +32% | +$533K |
|
|
VSM
2298
DELISTED
Versum Materials, Inc.
VSM
| $2.16M | ﹤0.01% |
57,100
+51,500
| +920% | +$2.01M |
|
|
NWHM
2299
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $2.16M | ﹤0.01% |
172,300
+55,500
| +48% | +$651K |
|
2300
BK Technologies
BKTI
$283M
| $2.16M | ﹤0.01% |
121,526
+1,306
| +1% | +$24.2K |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.